Among emerging immune factors, our group described earlier IgM antibodies against phosphorylcholine (anti-PC) as independent risk markers of atherosclerosis progression and CVD in the general population and also in patients with systemic lupus erythematosus (SLE)[8–10]. Here, CD40LG is linked to systemic lupus erythematosus.